“HIGH-DOSE-RATE AND LOW-DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER”, Вопр. онкол., vol. 65, no. 3, pp. 434–440, Mar. 2019, doi: 10.37469/0507-3758-2019-65-3-434-440.